<i>Musanga cecropioides</i> (Cecropiaceae) Attenuates Carbon Tetrachloride-Induced NonAlcoholic Fatty Liver Disease in Wistar Rats https://www.doi.org/10.26538/tjnpr/v2i11.4
Main Article Content
Abstract
Musanga cecropioides (M. cecropioides) is a medicinal plant used traditionally in Africa to induce labour, reduce elevated blood pressure, reduce high blood sugar as well as inhibit dysentery. In this study, the in vivo hepatoprotective activity of M. cecropioides was investigated in carbon tetrachloride (CCl4)-treated wistar rats. Animals were randomized into 5 groups with group 1 serving as control while animals in groups 2 to 5 were administered CCl4 (30% v/v with olive oil). Animals in groups 3 and 4 were pretreated with 250 and 500 mg/kg M. cecropioides, respectively, whereas group 5 animals (control group) were pretreated with 25 mg/kg silymarin (standard liver protective drug). Following treatment, alterations in biochemical parameters such as serum alanine amino-transferases (ALT), aspartate amino-transferases (AST), alkaline phosphatase (ALP), total protein (TP), Catalase (CAT), Superoxide Dismutase (SOD) and Malondialdehyde (MDA) as well as histopathological changes in the liver of experimental rats were investigated. Findings show increased serum biochemical and antioxidant profiles (AST, ALT, ALP and MDA), reduced TP, CAT and SOD as well as increased fat deposits and inflammatory infiltrates in the liver sections of animals treated with CCl4. However, following pretreatment with M. cecropioides and silymarin, altered biochemical parameters were observed to be retrieving towards normal while the histo-architecture of the liver was markedly improved. These results suggest that M. cecropioides could be a potent hepatoprotective agent against CCl4-induced liver
injury and these activities might in part, be attributed to the high total phenolic contents earlier reported to be present in this plant.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Benedict M and Zhang X. Non-alcoholic fatty liver disease: An expanded review. World J Hepatol. 2017; 9:715.
Than NN and Newsome PN. A concise review of nonalcoholic fatty liver disease. Atheroscl. 2015; 239:192-202.
Haddad TM, Hamdeh S, Kanmanthareddy A, Alla VM. Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: a systematic review and metaanalysis. Diab Metab Syndr. 2017; 11:S209-S216.
Bataller R, Rombouts K, Altamirano J, Marra F. Fibrosis in alcoholic and nonalcoholic steatohepatitis. Best Pract Res Clin Gastroenterol. 2011; 25:231-244.
Sanyal AJ, Friedman SL, McCullough AJ, Dimick-Santos L. Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop. Hepatol. 2015; 61:1392-1405.
Day CP and James OF. Steatohepatitis: a tale of two “hits”? : Elsevier, 1998. 842-845 p.
Koehler EM, Plompen EP, Schouten JN, Hansen BE, Darwish Murad S, Taimr P, Leebeek FW, Hofman A, Stricker BH, Castera L. Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: the Rotterdam study. Hepatol. 2016; 63:138-147.
Kwok R, Choi KC, Wong GL-H, Zhang Y, Chan HL-Y, Luk AO-Y, Shu SS-T, Chan AW-H, Yeung M-W, Chan JC-N. Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study. Gut. 2015; 65:1359-1368.
Wahlang B, Beier JI, Clair HB, Bellis-Jones HJ, Falkner KC, McClain CJ, Cave MC. Toxicant-associated Steatohepatitis. Toxicol Pathol. 2013; 41:343-360.
Joshi-Barve S, Kirpich I, Cave MC, Marsano LS, McClain CJ. Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences. Cell Mol Gastroenterol Hepatol. 2015; 1:356-367.
Zimmerman HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. Lippincott Williams & Wilkins, 1999.
Weber LW, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol. 2003; 33:105-136.
Song H-Y, Mao Z-M, Yang L-L, Liu T, Li D-F, Zhang L, Ge Y-L, Zheng P-Y, Liu P, Zhang X-Q, Ji G. Dangfei liganningCapsules Attenuate the Susceptibility of Rat Nonalcoholic Fatty Liver to Carbon Tetrachloride Toxicity. J Trad Chin Med. 2011; 31:327-333.
Van Herck MA, Vonghia L, Francque SM. Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide. Nutr. 2017; 9:1072.
Noyan T, Kömüroğlu U, Bayram I, Şekeroğlu M. Comparison of the effects of melatonin and pentoxifylline on carbon tetrachloride-induced liver toxicity in mice. Cell Biol Toxicol. 2006; 22:381-391.
Domitrović R, Jakovac H, Tomac J, Šain I. Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin. Toxicol Appl Pharmacol. 2009; 241:311-321.
Zhan Y-Y, Wang J-H, Tian X, Feng S-X, Xue L, Tian L-P. Protective effects of seed melon extract on CCl4-induced hepatic fibrosis in mice. J Ethnopharmacol. 2016; 193:531-537.
Hansen HH, Feigh M, Veidal SS, Rigbolt KT, Vrang N, Fosgerau K. Mouse models of nonalcoholic steatohepatitis in preclinical drug development. Drug Discov Today 2017; 22:1707-1718.
Recknagel RO, Glende EA, Jr., Dolak JA, Waller RL. Mechanisms of carbon tetrachloride toxicity. Pharmacol Ther. 1989; 43:139-154.
Manibusan MK, Odin M, Eastmond DA. Postulated carbon tetrachloride mode of action: a review. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2007; 25:185-209.
Karakus E, Karadeniz A, Simsek N, Can I, Kara A, Yildirim S, Kalkan Y, Kisa F. Protective effect of Panax ginseng against serum biochemical changes and apoptosis in liver of rats treated with carbon tetrachloride (CCl4). J Hazard Mater.2011; 195:208-213.
Zhang S, Lu B, Han X, Xu L, Qi Y, Yin L, Xu Y, Zhao Y, Liu K, Peng J. Protection of the flavonoid fraction from Rosa laevigata Michx fruit against carbon tetrachloride-induced acute liver injury in mice. Food Chem Toxicol. 2013; 55:60-69.
Dong D, Xu L, Yin L, Qi Y, Peng J. Naringin prevents carbon tetrachloride-induced acute liver injury in mice. J Funct Foods 2015; 12:179-191.
Li Z-W, Kuang Y, Tang S-N, Li K, Huang Y, Qiao X, Yu SW, Tzeng Y-M, Lo J-Y, Ye M. Hepatoprotective activitiesof Antrodia camphorata and its triterpenoid compounds against CCl4-induced liver injury in mice. J Ethnopharmacol. 2017; 206:31-39.
Akendengue B. Medicinal plants used by the Fang traditional healers in Equatorial Guinea. J Ethnopharmacol. 1992; 37:165-173.
Akendengue B and Louis A. Medicinal plants used by the Masango people in Gabon. J Ethnopharmacol. 1994; 41:193-200.
Fomogne-Fodjo M, Van Vuuren S, Ndinteh D, Krause R, Olivier D. Antibacterial activities of plants from Central Africa used traditionally by the Bakola pygmies for treating respiratory and tuberculosis-related symptoms. J Ethnopharmacol. 2014; 155:123-131.
Burkill HM. The useful plants of west tropical Africa. Volume 2: Families EI. Royal Botanic Gardens, 1994.
Ayinde B, Onwukaeme D and Nworgu Z. Oxytocic effects of the water extract of Musanga cecropioides R. Brown (Moraceae) stem bark. Afr J Biotechnol. 2006; 5:1350-1354.
Adeneye AA, Ajagbonna OP, Mojiminiyi FBO, Odigie IP, Ojobor PD, Etarrh RR, Adeneye AK. The hypotensive mechanisms for the aqueous stem bark extract of Musanga cecropioides in Sprague-Dawley rats. J Ethnopharmacol. 2006; 106:203-207.
Adeneye AA, Ajagbonna OP, Ayodele OW. Hypoglycemic and antidiabetic activities on the stem bark aqueous and ethanol extracts of Musanga cecropioides in normal and alloxan-induced diabetic rats. Fitoterapia 2007; 78:502-505.
Ayinde B, Omogbai E, Onwukaeme D. Hypotensive effects of 3, 4-dihydroxybenzyaldehyde isolated from the stem bark of Musanga cecropioides. J Pharmacog Phytother. 2010; 2:004-009.
Kamanyi A, Bopelet M, Lontsi D, Noamesi B. Hypotensive effects of some extracts of the leaves of Musanga cecropioides (Cecropiaceae). Studies in the cat and the rat. Phytomed. 1996; 2:209-212.
Dongmo A, Kamanyi A, Franck U, Wagner H. Vasodilating properties of extracts from the leaves of Musanga cecropioides (R. Brown). Phytother Res. 2002; 16:6-9.
Eboji O and Sowemimo A. Anti-inflammatory activty of Musanga cecropioides R. Br ex. Tedlie. Planta Med. 2014; 80:PD52.
Sowemimo A, Okwuchuku E, Samuel FM, Ayoola O, Mutiat I. Musanga cecropioides leaf extract exhibits antiinflammatory and anti-ociceptive activities in animal models. Rev Bras Farmacogn. 2015; 25:506-512.
Bhattacharya D, Pandit S, Mukherjee R, Das N, Sur T. Hepatoprotective effect of Himoliv®, a polyherbal formulation in rats. Ind J Physiol Pharmacol. 2003; 47:435-4490.
Cohen G, Dembiec D, Marcus J. Measurement of catalase activity in tissue extracts. Anal Biochem. 1970; 34:30-38.
Misra HP and Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972; 247:3170-3175.
Varshney R and Kale R. Effects of calmodulin antagonists on radiation-induced lipid peroxidation in microsomes. Int J Radiat Biol. 1990; 58:733-743.
Williamson EM, Okpako DT, Evans FJ. Selection, preparation and pharmacological evaluation of plant material. John Wiley & Sons, 1996.
de Medeiros BJL, dos Santos Costa K, Ribeiro JFA, Silva JOC, Barbosa WLR, Carvalho JCT. Liver protective activity of a hydroethanolic extract of Arrabidaea chica (Humb. and Bonpl.) B. Verl.(pariri). Pharmacognosy Res. 2011; 3:79.
Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol. 2004; 2: 1048-1058.
Ratziu V, Sheikh MY, Sanyal AJ, Lim JK, Conjeevaram H, Chalasani N, Abdelmalek M, Bakken A, Renou C and Palmer M. A phase 2, randomized, double‐blind, placebo‐controlled study of GS‐9450 in subjects with nonalcoholic steatohepatitis. Hepatol. 2012; 55:419-428.
Yang YS, Ahn TH, Lee JC, Moon CJ, Kim SH, Jun W, Park SC, Kim HC, Kim JC. Protective effects of Pycnogenol on carbon tetrachloride-induced hepatotoxicity in SpragueDawley rats. Food Chem Toxicol. 2008; 46:380-387.
Szymonik-Lesiuk S, Czechowska G, Stryjecka-Zimmer M, Słomka M, MĄldro A, Celiński K, Wielosz M. Catalase, superoxide dismutase, and glutathione peroxidase activities in various rat tissues after carbon tetrachloride intoxication. J Hepatobiliary Pancreat Surg. 2003; 10:309-315.
Boll M, Weber LW, Becker E, Stampfl A. Pathogenesis of carbon tetrachloride-induced hepatocyte injury bioactivation of CCl4 by cytochrome P450 and effects on lipid homeostasis. Z Naturforsch C J Biosci. 2001; 56:111-121.
Risal P, Hwang PH, Yun BS, Yi H-K, Cho BH, Jang KY, Jeong YJ. Hispidin analogue davallialactone attenuates carbon tetrachloride-induced hepatotoxicity in mice. J Nat Prod. 2012; 75:1683-1689.
Pratt DS and Kaplan MM. Evaluation of abnormal liverenzyme results in asymptomatic patients. N Engl J Med.2000; 342: 1266-1271.
Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol. 1999; 94:1018.
Gurung R, Purbe B, Gyawali P, Risal P. The ratio of aspartate aminotransferase to alanine aminotransferase (AST/ALT): the correlation of value with underlying severity of alcoholic liver disease. Kathmandu Univ Med J (KUMJ) 2013; 11:233-236.
Omoruyi S, Enogieru A, Momodu O, Ayinde B and Grillo B. Paracetamol-induced liver damage: Ameliorative effects of the crude aqueous extract of Musanga cecropioides. Niger J Health Sci. 2015; 15:2.
Kazeem M, Bankole H, Fatai A. Protective effect of ginger in normal and carbon-tetrachloride induced hepatotoxic rats. Ann Biol Res. 2011; 2:1-8.
Abraham P and Wilfred G. Oxidative damage to the lipids and proteins pf the lungs, testis and kidney of rats during carbon tetrachloride intoxication. Clin Chim Acta 1999; 289:177-179.
Aniya Y, Koyama T, Miyagi C, Miyahira M, Inomata C, Kinoshita S, Ichiba T. Free radical scavenging and hepatoprotective actions of the medicinal herb, Crassocephalum crepidioides from the Okinawa Islands. Biol Pharm Bull. 2005; 28:19-23.
Karakus E, Karadeniz A, Simsek N, Can I, Kara A, Yildirim S, Kalkan Y, Kisa F. Protective effect of Panax ginsengagainst serum biochemical changes and apoptosis in liver of rats treated with carbon tetrachloride (CCl4). J Hazard Mater.2011; 195:208-213.
Al-Yahya M, Mothana R, Al-Said M, Al-Dosari M, AlMusayeib N, Al-Sohaibani M, Parvez MK, Rafatullah S. Attenuation of CCl4-induced oxidative stress and hepatonephrotoxicity by Saudi Sidr honey in rats. EvidBased Complementary Altern Med. 2013; 2013:569037.
Mates JM, Perez-Gomez C, Nunez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem. 1999; 32:595-603.
Mahboob M, Rahman M, Grover P. Serum lipid peroxidation and antioxidant enzyme levels in male and female diabetic patients. Singapore Med J. 2005; 46:322.
Siswanto S, Arozal W, Juniantito V, Grace A, Agustini FD. The effect of mangiferin against brain damage caused by oxidative stress and inflammation induced by doxorubicin. HAYATI J Biosci. 2016; 23:51-55.
Ighodaro OM and Akinloye OA. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alexandria Med J. 2017; In press.
Chelikani P, Fita I, Loewen PC. Diversity of structures and properties among catalases. Cell Mol Life Sci. 2004; 61:192-208.
Ayinde BA, Onwukaeme DN, Omogbai EK. Isolation and characterization of two phenolic compounds from the stem bark of Musanga cecropioides R. Brown (Moraceae). Acta Pol Pharm. 2007; 64:183-185.
Tchouya GRF and Nantia EA. Phytochemical analysis, antioxidant evaluation and total phenolic content of the leaves and stem bark of Musanga cecropioides R. Br. ex Tedlie (Cecropiaceae), growing in Gabon. J Pharmacogn Phytochem. 2015; 3:192-195.
Davey MW, Stals E, Panis B, Keulemans J, Swennen RL. High-throughput determination of malondialdehyde in plant tissues. Anal Biochem. 2005; 347:201-207.
Yang J, Li Y, Wang F, Wu C. Hepatoprotective effects of apple polyphenols on CCl4-induced acute liver damage in mice. J Agric Food Chem. 2010; 58:6525-6531.
Ghaffari H, Ghassam BJ, Prakash H. Hepatoprotective and cytoprotective properties of Hyptis suaveolens against oxidative stress–induced damage by CCl4 and H2O2. Asian Pac J Trop Biomed. 2012; 5:868-874.
Adewale O, Adekeye A, Akintayo C, Onikanni A, Sabiu S. Carbon tetrachloride (CCl4)-induced hepatic damage in experimental Sprague Dawley rats: Antioxidant potential of Xylopia aethiopica. J Phytopharmacol. 2014; 3:118-123.
Mir A, Anjum F, Riaz N, Iqbal H, Wahedi HM, Khattak JZK, Khan MA, Malik S. Carbon Tetrachloride (CCl4)-induced hepatotoxicity in rats: Curative role of Solanum nigrum. J Med Plants Res. 2010; 4:2525-2532.
Sahreen S, Khan MR, Khan RA. Hepatoprotective effects of methanol extract of Carissa opaca leaves on CCl4-induced damage in rat. BMC Comp Altern Med. 2011; 11:48.